Camlin Fine Sciences Limited (532834) Earnings Call Transcript & Summary
November 10, 2025
Earnings Call Speaker Segments
Operator
operatorLadies and gentlemen, good day, and welcome to Camlin Fine Sciences Q2 and H1 FY '26 Earnings Conference Call hosted by InCred Equities. [Operator Instructions] Please note that the conference is being recorded. I now hand the conference over to Mr. Chaitya Doshi from InCred Equities. Thank you, and over to you, sir.
Chaitya Doshi
analystThank you. On behalf of InCred Equities, I thank you all for joining the 2Q H1 FY '26 Earnings Conference Call of Camlin Fine Sciences Limited. From the management team, we have with us Mr. Ashish Dandekar, Chairman and Managing Director; Mr. Nirmal Momaya, Managing Director; and Mr. Santosh Parab, Chief Financial Officer. Before I hand over the call to the management team, I would like to draw your attention to the safe harbor statement in the investor presentation. Over to Mr. Ashish Dandekar, sir for opening remarks. Thank you.
Ashish Dandekar
executiveThank you. Welcome, ladies and gentlemen, to this call. I know your time is precious, so we'll get on with it. Santosh will give you a brief of the quarter's performance, after which we will answer your questions. Santosh?
Santosh Parab
executiveYes. Thanks, Ashish. Good evening, everybody. Quickly to the financial statements. We had a revenue of around INR 460 crores in this quarter, which is a growth of 8.6% over last quarter. The increase was fueled by the increase in Straights and Blends vertical of ours, where we grew our turnover in both the Straights business of TBHQ, BHA and also the Blends business has increased during this quarter. As you know, Aroma, another vertical of ours, the volumes have increased. However, the net realization there has been subdued due to tariff situation. Overall costs are stable. In Straights business, we have realization pressure because the prices are under pressure, even though costs have remained stable, especially the heightened local competition coming from local in the sense in India. There are competition coming on TBHQ, BHA. However, we have hold on to our volumes. Our volumes have increased this quarter by around 40%. This was mainly because last quarter, if you remember, we had a shutdown there. But we have come back on volumes in the Straights. Blends business has been growing at around 8%, which has grown by 8% in this quarter. Our margins have improved as compared to last quarter from -- by around 2%. It's around 46% this quarter. It was 44% -- 43%, 44% last quarter. Last quarter, we had certain shutdowns and as the gross margins were impacted. This quarter our Tarapur plant as well as Dahej plant have been working at an optimum capacity utilization, and that has helped us to get back to 46% gross margin. Of course, we could have got more margins, but for the impact on the tariff pressure on the volume -- vanillin realization. Vanillin business volume has increased almost by 35%. The sales volume has increased by 35% as compared to the last quarter. But the realizations have been under pressure, especially due to the 50% tariff, which has been levied on Indian exports to U.S. and that has put pressure on the realizations. Prices have been -- costs have been stable. There's no increase in cost, because raw material price and crude prices have been under control. Coming to the other costs, if you remember, there was some onetime expenditure happening on employees cost, but we had also said that we would be strengthening our Blends spend because we are looking at a lot of exciting prospects in our Blends business. And hence, we have been strengthening our employees, especially in Blends marketing employees almost in all our key regions of U.S. and Brazil, even Europe. The new Vitafor acquisition in Belgium, in India, we have almost added 20 people this quarter also. And that's why the employee cost, despite being a onetime hit last year, has been remaining at the same level, and it will remain at this level now of this quarter. In fact, we have planned to add a few more heads in marketing in various sub verticals in those Blends business. So there could be a small -- some percentage increase in employee cost going forward. As far as other cost -- other expenses are concerned, there also we had to absorb fixed cost last -- in the last quarter because of the closure of -- shutdown of the plant. But this time, the volumes are higher. As I said, volumes in our Tarapur plant were almost more than 40%. Even vanillin plant, we had additional 35%. Our plant was working between 50% to 60%, vanillin. Obviously, that has got the other cost. And the end result was an EBITDA of around INR 33 crores this year -- this quarter at 7.27% as against INR 19-odd crores in last quarter, there's an increase. But as I said, margins on cost side, we have been fairly stable, but for the Blends strength, which we have increase in employee cost. However, there are certain pressures on the realizable values of our products. Our Blends business sectorally remains exciting and good. We are growing. Of course, in U.S. is a geography where we have seen certain sluggishness, especially which was also due to the inflationary thing in U.S. But we are certain that we'll get back to the original levels, and we will be able to achieve the generally budgeted thing of growing at around 18% to 20% on Blends year-to-year. This will be supported by the Blends strength, which we are increasing. As well as inorganic growth We had just -- are on the verge of starting share with new acquisition in France that will also come. It will become a subsidiary sometime in this quarter, which will bring additional revenue. So we feel that we are on track for the growth which we have been seeing in Blends. Coming down to the profit, yes, we had a loss last year -- last quarter because of the shutdowns and other things. But we had almost -- it's almost 0, and it will improve as we go to the subsequent quarters. As far as loan book. Coming down to the balance sheet, we didn't have any big fixed asset expenditure apart from what we had to do for maintenance and other things. Our gross debt situation has remained stable. It was around INR 645 million to INR 640 million. We did repay certain loans, but as we have been always saying that this repayment will -- we have to go for working capital also because your revenue keeps on increasing. The net debt was INR 490 million, it has been at INR 520 million. That's basically we had some right issue money, which has been used. But largely, the gross debt is expected to remain at the same level. Correspondingly, if you see interest cost has not gone up much. Net of fixed cost, we have been at the same level. So all in all, this is -- we are an increasing trend despite all the issues of tariffs and the struggle on the realization. We are making, on a -- I will say, on a growth part, and I think this will -- this path will remain as the year progresses. Thank you. You can open the question floor. Thanks.
Operator
operator[Operator Instructions] The first question is from the line of Rehan Laljee from Coheron Wealth.
Rehan Laljee
analystFirst of all, I just had a couple of questions. In the Q1 con call, you had mentioned we have about 3 to 4 months of -- there's 3 to 4 months of channel inventory for vanillin. And I see on a Q-o-Q basis, you've done really well in a challenging time. So kudos to you guys for that. Could you help us understand how is the channel looking currently at the moment? Is the destocking complete? That's my first question.
Nirmal Momaya
executiveThe destocking in the U.S. is expected to be completed by Q4 of this year. And in Europe, it is expected to be cleared by Q1 of FY '27 because Europe, the antidumping duty was levied only in July. So there was a large amount of channel stocks lying in Europe.
Rehan Laljee
analystUnderstood. Because on the Q1 con call, you had mentioned you're expecting by November to be cleared the entire channel. So are we seeing a delay on that?
Nirmal Momaya
executiveYes, I think so. I mean there is -- also there is the effect of tariffs, which has played a role on overall demand in the U.S., which is now opening up. So we expect by Q1 for it to be -- the channel stocks to be empty and we get a good position in the market.
Rehan Laljee
analystAnd just for this quarter, what would have been your blended realization, around $12, $13?
Nirmal Momaya
executiveAround $12, yes.
Santosh Parab
executive$12 is sell price and the net price -- net of freight and other things, which we bore, it's between $11 and $12.
Rehan Laljee
analystUnderstood. So sir, I wanted to confirm on that, that year-on-year if we look, not quarter-on-quarter because I understand you took the plant shutdown. If we look at it year-on-year, your sales have improved by about 8%, 9% for the quarter, out of which vanillin has improved specifically by about 70%, 75% year-on-year. But still your gross margin is down about 200 bps. So I mean, it just doesn't -- just wanted to understand more on that.
Santosh Parab
executiveSo last year, I've been mentioning that there is certainly a price pressure here. In last year's Straights like TBHQ and BHA was been sold at $8.5 and $9. The prices have come down to $7. Similarly, vanillin, the situation was totally different. We were hardly producing at that moment of time. But generally, the margins are lower. The cost have almost remained same year-on-year, but the whole trouble is the realizable pricing is under pressure, and that has taken out around 2% to 3% of our margins quarter-on-quarter.
Rehan Laljee
analystAnd considering that Europe now scheduled their fresh contracts for vanillin, are we seeing $15, $16 kind of realization is what has been the historical median. So are we seeing those kind of prices and contracts coming in for us?
Nirmal Momaya
executiveNo, not in Europe, not as yet. Like I said, in Europe, the channel stocks will remain till end of the year, till March at least. So the price realization is in the $12, $13. But we will see it move once the channel stocks are improved.
Rehan Laljee
analystAnd do you feel you are confident of reiterating your guidance for about 2,500 to 3,000 tons this year for vanillin and also Blends, because on H1 -- Y-o-Y basis, you're about 7%, 8% kind of growth. So do you think you guys are going to stick to that for this year, considering the tariff headwind and other macro factors?
Nirmal Momaya
executiveI think vanillin, we are -- how much have we done now?
Santosh Parab
executiveWe have done -- for the half year, we have done almost 1,300 tons.
Nirmal Momaya
executive1,300. So yes, we are good for the 2,500. And for the Blends also, we are -- the 20% that we are seeing between 18% to 20%, I think we are okay for that as well.
Rehan Laljee
analystOkay. Because in H1 basis, you're still at high single digits. So you feel that, that will cover up in H2?
Nirmal Momaya
executiveYes. Also, there is an acquisition, which will add some numbers.
Rehan Laljee
analystOkay. So that includes that 18%, 20%.
Nirmal Momaya
executiveYes.
Operator
operatorThe next question is from the line of Satish Kumar from InCred Capital.
Satish Kumar
analystSo I just wanted to ask one thing. This is regarding the guidance that was there of around INR 2,000 crores to INR 2,100 crores kind of sales, whether that will be achieved or are we changing it?
Nirmal Momaya
executiveNo, that will be on -- we are on line for about INR 2,000 to INR 2,100.
Satish Kumar
analystAnd sir, also, what will be the current prices, the retail prices of vanillin in U.S.?
Nirmal Momaya
executiveIn U.S., the prices are -- minimum is $19. But we are seeing now some businesses even at $20 plus.
Satish Kumar
analystOkay. So assuming, sir, that if Trump tariff comes down to 15%, what we can realize, sir? I mean just -- I'm not asking for a guidance, I'm just asking a rough idea.
Nirmal Momaya
executiveNo. So the pricing, I don't think will come below that because the local competition that we have is pricing it at around the same $20 price. So our realization should improve by at least $3, $4 -- whatever depending on the tariff situation, what it lands at.
Satish Kumar
analystOkay. Got it, sir. And sir, I also wanted to understand regarding Vinpai. When will the integration happen, sir?
Nirmal Momaya
executiveSo we are expecting it by November end. It should be -- we're just waiting for approvals from the stock exchanges for the swap. And once that is done, within 15 days we will do the swap. So by end of November, it should be done.
Satish Kumar
analystSo we will start consolidating it from this quarter -- for [ 1 month ].
Nirmal Momaya
executiveCorrect.
Operator
operatorThe next question is from the line of Surya Narayan Patra from PhillipCapital (India) Private Limited.
Surya Patra
analystMy first question is on the U.S. business. So the North American business sequentially has seen a kind of impact. So what is this business getting impacted, sir? Is it the export from India or it is pricing or it is the tariff? What is really getting impacted here?
Nirmal Momaya
executiveIn the U.S., the one impact that had happened was there was a bit of a slowdown in the pet food business in the last 2 quarters, which now seems to have improved and is picking up again. So structurally, the natural -- that we are selling into the U.S. was getting replaced by some synthetic at a lower end of the market. So which I think, again, now they are back on track, and we should be back on track on the U.S. business.
Santosh Parab
executiveSurya, to add to what Nirmal is saying, we have been selling vanillin through U.S. So INR 96 crores of revenue last quarter also had vanillin. Now to -- if we import, then we have to bear the duty first that impacts our working capital. So in this quarter, we have tried to do direct sales rather than routing it through U.S. So the dip of INR 96 crores to INR 69 crores is not only of Blends. There is reduction because of vanillin. Blends, we have -- it's not gone down. It's like 5% small on animal nutrition and other things. Because the turnover is shown of entire -- in earlier time, there was no vanillin sold in U.S. So it was very pretty safe to assume that it was Blends. But now the case is different, at least for this quarter. Last quarter, there was vanillin sale in U.S. because we had selling through U.S. to get better margins. Now to circumvent the working capital requirement and the vanillin to be -- there is duty on us, we are directly selling.
Surya Patra
analystOkay. Sir, hypothetically, just wanted to understand, see, if the -- we know that the historical average for vanilla has been -- in terms of pricing has been in the range of around, $12 kind of. So what we are currently getting even for the U.S. market right now, even after the tariffs? So if this tariff situation continues like that for, let's say, extended period, so then what will really restrict us from enhancing and expanding the volume?
Nirmal Momaya
executiveNo. So Surya, the point is that the volumes were impacted, as we said, was because of the channel stock. Once the channel stock is cleared, irrespective of what the tariffs land at, whether they continue at the same or they come down. If they go up from where it is, of course, our net realization will get impacted because the final price in the market is around $20. Now our net realization today is $12 because of the tariff in between. So it's -- really a calculation is now really where the tariffs will land at. If they go more than $55, this will come down, net realization. If it comes below $55, our net realization will go up.
Santosh Parab
executiveJust to add also to this, if the prices remain at $12, channel stocks are out, we will be increasing our production to much more. As you know, we are running at 50%. So the cost is higher. So we may be saving around $1, $1.5. If we go on 100% with $12 realization only, there will be some margin improvement, though not -- the turnover doesn't increase. But as a Nirmal said, the tariff situation is different, there will be a much higher margin increase.
Surya Patra
analystCorrect. Yes, yes. fine.
Nirmal Momaya
executiveThe way to look at it, Surya -- sorry, Surya, the way to look at it is, all our costs of running the vanillin plant are in today. Whatever incremental sales that I do on vanillin will -- my RMC today is, say, at roughly about $8 and if my realization is $12, I get a straight $4 margin on every incremental sale that I do. Because in my these numbers, all my costs today are in. 100% of the costs are in.
Surya Patra
analystYes. Yes. So then it is a question that, okay, when the on-ground demand will really pick up after the deduction of the inventory.
Nirmal Momaya
executiveCorrect. That is the real question. And for that, our expectation is by Q4, it should start picking up in the U.S. and Q1 in Europe.
Surya Patra
analystOkay. And about the non-U.S., non-Europe market, what is the trend and what dynamics that you are seeing, sir, for vanillin?
Nirmal Momaya
executiveTrend is very bad because the Chinese are desperate selling at $7, $7.5. So it's not really a market that you can play in. But of course, we do have some markets where -- especially in F&B, where we do sell small volumes, and we are yet focusing on those markets and trying to build -- it will not be very large volume. But whatever we do get is always -- it always helps.
Surya Patra
analystOkay. My next question was about the Blends business. So if I remember last time that you have been mentioning about creating the franchisee -- the branded franchisee in the Blends in the advanced markets. And today in the opening remark also, it has been mentioned that there is a field force expansion likely.
Nirmal Momaya
executiveRight.
Surya Patra
analystSo if you can, sir, give some sense that, okay, what is the field force that you are currently having for the Blends business, what you are currently having? And what metrics that you do follow in terms of revenue per sales representative or something like that? And what is the field force you are expanding? And what timeline that would be required to achieve an optimal kind of revenue per representative on that front?
Nirmal Momaya
executiveSo in every market, Surya, the metrics is different because every geography, the cost structures are very different. So we can't really generalize and say that our metrics is -- in the U.S. is very different than it is in India. It's very different in Mexico as compared to Brazil. So it's again market to market. However, on the number of people, I mean, we have expanded the field force by almost 31 people in this quarter, starting -- I mean, in this last quarter, which the impact of that, we will start seeing from -- typically, it takes 6 months for the impact to start showing once somebody is onboarded. So you will start seeing the impact of this additional by Q4 and Q1 of next year. However, we had also added people, say, 6 months ago -- also in Q1, we had added people -- a few people. So that will also start showing results from Q4 onwards.
Surya Patra
analystSo that means, is it fair to say, sir, this is a 10%, 20% kind of field force expansion or in what -- any numerical sense if you can provide?
Nirmal Momaya
executiveNo, it's more than 10%. It's almost -- I think we were at 21% increase in field force.
Surya Patra
analystHence, accordingly the employee cost we'll see a kind of a swing to the tune of, let's say, 5%, 7% incremental.
Nirmal Momaya
executiveSo yes. So it's -- already you've seen this quarter, what this is. Beyond this, there will be a little bit more than that in -- by the next quarter because we are also adding a few more people. But more or less, it will be on these lines. And that's why we are projecting by adding 20% sales force, we are projecting at least 20% growth in the next year.
Santosh Parab
executivePatra, just to add to this. There is no -- we are not absorbing any increase in the employee cost because there was a onetime bonus which we had given last quarter. So this increase in employee cost is getting hidden because of that. So if we -- so there is -- we have added people and salaries have increased. In fact, if there was a onetime in first quarter, my salaries should have gone down. It has not gone down because we are adding people.
Surya Patra
analystOkay. Just last one point, sir, from my side. See, we know that there is a kind of over inventory for vanilla, both in U.S. and Europe. But we also know that this is the time that by December, we signed the contracts for the next full year. So on that front, what feedback that you are getting, whether there is --
Nirmal Momaya
executiveNo. So right now, people are not signing for the full year. Typical contracts are for 1 quarter or 2 quarters because they have some stocks also and some contracts spilled over. So that is the reason why it is very difficult to gauge what ultimately that volume will turn into. But yes, the indication is, I mean, we did win some contracts for the next -- first half of the next year, all at these prices that we are discussing. And we are also kind of happy that it doesn't go on -- the contract should be too long because if there are any changes in the tariffs or whatever, we need to be careful on how we are quoting.
Surya Patra
analystSo that means if the tariff situation eases, then our first target would be spot market rather than the contractual price.
Nirmal Momaya
executiveNo. I mean, -- in the contract, it is DDP price, right? So for us, we are taking those contracts. It's not that we are not. We are signing up as we are bidding. And we've got -- we've also got some contracts. Already the bids we have won for H1 of next calendar year. So there will be a strong -- we will tie up for H1 a decent volume through contracts. And of course, then the rest is the spot market.
Operator
operatorThe next question is from the line of [ Raj Agrawal ] from CJ Shah Family Office.
Unknown Analyst
analystYes. Sir, I just wanted to understand on this European business, sir, what are our plans for this business? And by when will these losses, even now in discontinued operation, but like how long will this continue?
Santosh Parab
executiveSo as we have been saying that we are -- we have mothballed the diphenol plant, and we are trying to divide the Blends business in Europe. On an average, we should have INR 5 crores, INR 6 crores of quarterly hit. There are some expenditures which get spilled over in the quarters. So last quarter, it was INR 5 crores, it has become INR 8 crores. But on an average for the year, it will be -- for this year, it will be around INR 25-odd crores. Going forward, next year onwards, it will come down to INR 2 crores per quarter. This quarter, it will be there. So this cost will be there for this discontinued business. We also have other discontinued business of China, which has a cost of around INR 1 crore of this -- INR 1 crore cost, which we have already initiated liquidation proceeding. Then last -- there will be no cost going from FY '27.
Unknown Analyst
analystOkay, sir. This was helpful. And sir, one more question. Sir, have we signed any contracts at this kind of prices for next year as well? Or basically, we are only signing these contracts till the channel inventory is there in the system?
Nirmal Momaya
executiveSo we have signed some contracts for H1 calendar year '27.
Unknown Analyst
analystThat is at these prices, roughly $12 prices?
Nirmal Momaya
executiveYes. No, as per DDP price, which is at around $19.5.
Operator
operator[Operator Instructions] The next question is from the line of [ Rohan Mehta from Fincom Family Office ].
Unknown Analyst
analystSo firstly, I want to understand what sort of trends are you observing, okay, first in the month of October and currently ongoing for the month of November when it comes to vanillin, A, in terms of the offtake that you're seeing and also in terms of the pricing. So is the pricing more comparable to the softness you have observed in Q2? Or are you seeing prices slightly go up?
Nirmal Momaya
executiveIt's the same. We answered that question. We are seeing the prices at the levels that we've seen in the past. The DDP price in the U.S. is around $19, $20. And in Europe, it is $12 to $13.
Santosh Parab
executiveThe volume trend also remains. We have done around 700 tons in this quarter.
Nirmal Momaya
executiveIn October, November also, it will continue on similar lines.
Santosh Parab
executiveSimilar lines.
Unknown Analyst
analystOkay. And in terms of your vanillin mix, so last quarter, you had guided that Europe is going to be 40% of the mix. So given that there is uncertainty when it comes to Trump tariffs, are you looking to shift more of this to Europe, increase your revenue mix over there? Is there any change in strategy?
Nirmal Momaya
executiveNo. No change in strategy at this point of time. We're continuing with the same strategy because U.S. is a bigger market. So it will always have a bigger share in the total mix. So with the Trump tariffs also -- ultimately, we have a lot of capacity, which we need to fill up first. So once we fill up the capacity, we have to see on what the final strategy will be.
Santosh Parab
executiveThere are channel stocks also in Europe.
Unknown Analyst
analystRight. And lastly, on Syensqo restarting their synthetic vanillin unit in France. I wanted to understand, has it to some extent, cannibalized your sales in Europe, considering that now there is an additional capacity coming up online that can actually service the clients in Europe? Or do you feel that you will still be able to push up the volumes, which you were on track to guide?
Nirmal Momaya
executiveThey have a capacity of 5,000 tons. In Europe, the market is about 8,000 to 8,500 tons. So there's a gap of 3,500 tons to be filled from imports into Europe, which is what we are trying to position ourselves to fill.
Operator
operatorThe next question is from the line of Satish Kumar from InCred Capital.
Satish Kumar
analystI just wanted to ask regarding the salespeople, when you are hiring them, will you be doing the sales for Vinpai as well or you want to hire separately for Vinpai?
Nirmal Momaya
executiveNo, no. So they do for all the whole basket of products. And of course, for Vinpai, Vinpai itself will also hire more people as we go along. But at this point of time, the 31 that we've added does work on different verticals. There is pet food, there is animal nutrition, there is human food. As far as the human food team is concerned, they sell even the Vinpai products.
Satish Kumar
analystOkay. Got it, sir. I just wanted to ask on the Vinpai itself. What is the revenue right now, sir, monthly run rate of revenue in Vinpai.
Nirmal Momaya
executiveThey are at about EUR 1 million plus per month current --
Satish Kumar
analystOkay. And sir, in Europe also, we signed the contract for vanillin on the deliver to client basis, right, sir?
Nirmal Momaya
executiveYes.
Satish Kumar
analystOkay. So it means all the tariffs, freight, et cetera, whatever it is that is in Europe as well as the U.S. has to be bought by us.
Nirmal Momaya
executiveCorrect.
Santosh Parab
executiveYes.
Satish Kumar
analystOkay. So $20 that we have signed for next year, $19.5, $20, what you said, sir?
Nirmal Momaya
executiveNo, that's for the U.S. market. That's for U.S. market, not for Europe. So the same customer has different prices for different markets.
Satish Kumar
analystRight. So this is delivered to customer in U.S.?
Nirmal Momaya
executiveYes.
Operator
operatorThe next question is from the line of Neeraj from White Pine Investment Management Private Limited.
Niraj Mansingka
analystOnly 2 questions. One, if the local market U.S. pricing is, say, $12, how much would we net realize after whatever adjustments you have for all the logistics taxation, et cetera?
Santosh Parab
executiveSo net realization itself $11, $12. The selling price in U.S. is $18, $19.
Niraj Mansingka
analystin terms of Europe. I am talking of Europe. So if the Europe prices --
Santosh Parab
executiveFor Europe, we are getting the same realization.
Nirmal Momaya
executiveNet realization.
Santosh Parab
executiveNet realization is in the same level as U.S. U.S. should have been more, but for the duty. Higher duty in U.S. The net realization in Europe is also $11, $12.
Niraj Mansingka
analystOkay. The second question is, if tomorrow, say, the tariff is reduced, whatever number. So after how many days will you start getting that realization because the contracts you have signed at $12? Or is it like the moment the import duty goes to, say, 15% or 20%, your realization increases next year itself. So I wanted to know that delay.
Santosh Parab
executiveIt will be on the -- what the -- how the duty is reduced by the U.S. government.
Niraj Mansingka
analyst[Indiscernible] how many days delay will it come to you, that money? For example, if the tariff is reduced to, say, 20% on, say, 15th of November, you have signed contracts with the customer already for a quarter down the line. So will you get $12...
Nirmal Momaya
executiveSo yes, it depends on whether the contract is CIF or it is DDP. So based on that. If its DDP, the next day you get it. If it is CIF till the next time the contract comes up, you have to continue to price it at the same price.
Niraj Mansingka
analystOkay. The question is how much -- what -- are our contracts CIF or the other one?
Nirmal Momaya
executiveNo, it's a combination. Some are CIF, some are DDP.
Santosh Parab
executiveMainly its DDP.
Niraj Mansingka
analystSo the full impact of -- even if the tariff is reduced today, the full impact will be at least a quarter.
Nirmal Momaya
executiveNo. On the DDP contract will be immediate.
Santosh Parab
executiveYes, but that is partial, right? Because some contracts are CIF. So until you complete the CIF contract, your next lot realization will be only higher, right? The same lot wouldn't be higher. Am I right?
Nirmal Momaya
executiveYes.
Santosh Parab
executiveAnd what is the maximum outward contract you have signed, sir?
Nirmal Momaya
executiveThat is confidential. We can't give you those numbers.
Santosh Parab
executiveOkay. No, I was trying to see -- only thing I was trying to see is if the tariff is reduced by how many days or months will your full realization be coming to you? That's the only thing I wanted to know.
Operator
operator[Operator Instructions] The next question is from the line of [ Aditya from PolyLab Family Office ].
Unknown Analyst
analystMy question is regarding the Dahej facility ramp up. So we commercialized Dahej diphenol facility. And it was expected to yield an incremental EBITDA of about INR 60 crores to INR 70 crores at a full capacity utilization. And at a cost advantage of maybe $1 to $1.5 per kg. So can you just give me the current status of the current utilization rate and the incremental EBITDA that we are doing?
Santosh Parab
executiveI can tell you what is the current utilization and I'd said that it's around -- it's 50% to 55%. We produce -- we sold around 700 metric tons. Our capacity is 6,000 per annum. That's around 50% capacity utilization. At that utilization, our costs are $9.5, $10. At full capacity, it will come to $8.
Unknown Analyst
analystOkay. And that will eventually give some EBITDA margin improvement, let's say, in FY '27 for the --
Santosh Parab
executiveThat's a multiplier. I've told you the numbers. The whole thing is the realizable value. It's a multiplier. You can multiply.
Operator
operator[Operator Instructions] The next question is from the line of Satish Kumar from InCred Capital.
Satish Kumar
analystSir, last question on my side. Will you be giving any guidance for next year, sir, in the vanillin sales or Blends sales?
Nirmal Momaya
executiveYes. So vanillin, I think we should be looking at about 4,000 tons in the next year. And the Blends business also, we are looking at growing it by 20%. So these are the 2 big drivers of growth for the next year.
Operator
operatorLadies and gentlemen, that was the last question for today. I would now like to hand over the conference to the management for closing comments.
Ashish Dandekar
executiveThank you. Thank you for being with us, ladies and gentlemen. We look forward to interacting with you for the next call next quarter. Thank you.
Operator
operatorThank you. On behalf of Camlin Fine Sciences and InCred Equities, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Camlin Fine Sciences Limited transcript — plus 251,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Camlin Fine Sciences Limited earnings transcripts and 251,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.